⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1784598 | 1.00 | — | — | |
| SCHEMBL10511638 | 0.79 | — | — | |
| SCHEMBL10511644 | 0.79 | — | — | |
| SCHEMBL9009862 | 0.77 | — | — | |
| SCHEMBL9160887 | 0.77 | METAP1 (0.33) | — | |
| SCHEMBL4474596 | 0.75 | — | — | |
| SCHEMBL4474600 | 0.75 | — | — | |
| SCHEMBL789104 | 0.73 | — | — | |
| SCHEMBL789287 | 0.73 | — | — | |
| SCHEMBL789595 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8450533-B2 | Cyclopropanation process | GIVAUDAN SA (CH) | 2013-05-28 | — | — | US | disclosed |
| US-8450533-B2 | Cyclopropanation process | GIVAUDAN SA (CH) | 2013-05-28 | — | — | US | disclosed |
| US-8450533-B2 | Cyclopropanation process | GIVAUDAN SA (CH) | 2013-05-28 | — | — | US | disclosed |
| US-8034811-B2 | Hydroxamic acid esters and pharmaceutical use thereof | LEO PHARMA A/S (DK) | 2011-10-11 | — | — | US | disclosed |
| US-20110124924-A1 | Cyclopropanation Process | GIVAUDAN SA (CH) | 2011-05-26 | — | — | US | disclosed |
| US-20110124924-A1 | Cyclopropanation Process | GIVAUDAN SA (CH) | 2011-05-26 | — | — | US | disclosed |
| US-20110124924-A1 | Cyclopropanation Process | GIVAUDAN SA (CH) | 2011-05-26 | — | — | US | disclosed |
| WO-2009023980-A1 | CYCLOPROPANATION PROCESS | GIVAUDAN SA (CH) | 2009-02-26 | — | — | WO | disclosed |
| US-7384906-B2 | Aliphatic compounds as fragrants with musk characteristics | GIVANDAN SA (CH) | 2008-06-10 | — | — | US | disclosed |
| US-20070244117-A1 | Novel Hydroxamic Acid Esters and Pharmaceutical Use Thereof | LEO PHARMA A/S (DK) | 2007-10-18 | — | — | US | disclosed |
| EP-1565420-B1 | ALIPHATIC COMPOUNDS AS FRAGRANTS WITH MUSK CHARACTERISTICS | GIVAUDAN SA (CH) | 2006-10-18 | — | — | EP | disclosed |
| US-20060052277-A1 | Aliphatic compounds as fragrants with musk characteristics | GIVAUDAN SA (CH) | 2006-03-09 | — | — | US | disclosed |
| EP-1565420-A1 | ALIPHATIC COMPOUNDS AS FRAGRANTS WITH MUSK CHARACTERISTICS | Givaudan SA (CH) | 2005-08-24 | — | — | EP | disclosed |
| WO-2004050595-A1 | ALIPHATIC COMPOUNDS AS FRAGRANTS WITH MUSK CHARACTERISTICS | GIVAUDAN SA (CH) | 2004-06-17 | — | — | WO | disclosed |